Research Solutions Inc (NASDAQ: RSSS). Extremely significant negative changes in investment behavior have recently occurred: negative upside/downside volume developed, and the stock fell on very heavy volume. Recent significant negative changes in fundamentals have affected […]
MaxLinear Inc (NASDAQ: MXL) stock enjoyed a major increase of 11.0% on 12/4/24. The shares closed at $19.32. Moreover, trading volume in this advance was exceptionally high at 356% of normal. The stock has risen […]
For its third fiscal quarter (ending September 30), KNOT Offshore Partners LP (NYSE: KNOP) has reported a -150% decline in E.P.S. from $0.32 a year ago to $-0.16 in the current quarter. For the latest […]
Himax Technologies Inc (NASDAQ: HIMX) stock closed at $6.04 on 12/4/24 after a major increase of 11.0%. Moreover, exceptionally high trading volume at 327% of normal accompanied the advance. The stock has risen 12.3% during […]
Daktronics Inc (NASDAQ: DAKT) has reported E.P.S. of $0.46 for its second fiscal quarter (ending October 31) versus $0.05 for the same period a year ago — an increase of 820%. E.P.S. were $0.63 for […]
Cross Country Healthcare Inc (NASDAQ: CCRN) stock closed at $18.16 on 12/4/24 after a major increase of 62.7%. Moreover, exceptionally high trading volume at 1021% of normal accompanied the advance. Relative to the market the […]
On 12/4/24, Cidara Therapeutics Inc (NASDAQ: CDTX) stock enjoyed a major increase of 12.6%, closing at $19.95. Moreover, this advance was accompanied by exceptionally high trading volume at 244% of normal. The stock has been […]
Thor Industries Inc. (NYSE: THO) has reported a loss for its first fiscal quarter (ending October 31) of $-0.03 versus $1.01 for the same period a year ago — a decline of -103%. This performance […]
For its fourth fiscal quarter (ending October 31), Royal Bank of Canada (NYSE: RY) has reported a 1% increase in E.P.S. from $2.90 a year ago to $2.92 in the current quarter. This result exceeded […]
Greif Inc. (NYSE: GEF) has reported earnings for its fourth fiscal quarter (ending October 31) of $1.35 versus $1.45 for the same period a year ago — a decline of -7%. However, this result exceeded […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research